Ottimo Pharma logo

Ottimo Pharma

Ottimo Pharma is a clinical-stage biotech company developing PD-1/VEGFR2 dual-paratopic antibodies to extend the lives of cancer patients.

Facts

Sectors
Biotechnology, Pharmaceuticals, Biopharmaceutical R&D
Stage
Clinical-stage

Online